Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001415889-17-001081)

Filing Details

Accession Number:: 0001415889-17-001081
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-07-03 16:57:26
Reporting Period:: 2017-06-30

Filing Date:: 2017-07-03
Accepted Time:: 2017-07-03 16:57:26
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1604191	Azurrx Biopharma Inc.	AZRX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1217674	Matthew Balk	Po Box 2422 Westport CT 06880		No	No	Yes	No
1681335	Pelican Partners Llc	Po Box 2422 Westport CT 06880		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2017-06-30	100,000	$3.00	1,787,796	No	4	S	Direct
Common Stock	Disposition	2017-06-30	60,000	$3.50	1,727,796	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

Securities were sold in private, negotiated transactions. The purchasers agreed to not sell the securities purchased for a period of 120 days, resulting in a lock-up during such period.